跳转至内容
Merck
所有图片(1)

Key Documents

BHL-89

98070109, human lymph (axillary), Lymphoblastoid

登录查看公司和协议定价


About This Item

分類程式碼代碼:
41106514

product name

BHL-89, 98070109

生物源

human lymph (axillary)

增長模式

Suspension

染色體組型

Hyperdiploid, modal no. 47, chromosome 1 trisomy, 15 monosomy, +14q+

形態學

Lymphoblastoid

產品

Not specified

受體

sIgM,CD22,BB1,HLA-ABC,GnRH

技術

cell culture | mammalian: suitable

相關疾病

cancer

運輸包裝

dry ice

儲存溫度

−196°C

細胞系來源

Human B-type EBNA negative lymphoma

細胞系描述

The cell line BHL-89 was established from a 56 year old female patient with chronic lymphoid leukaemia (CLL). The B-cell type cells were shown to express CD9, CD22, CD71,HLA-ABC, BB1, GnRH and surface IgM. Cloning efficiency in soft agar was found to be between 20-60% and population doubling time was 48 hours. BHL-89 cells are Epstein-Barr nuclear antigen (EBNA) negative. They have been shown to be tumourigenic in immunosuppressed mice, sensitive to dibromodulcitol and resistant to the phorbol ester TPA. The cell line was found to be positive for BCL-2 protein and produces small amounts of interferon. Lymphoblastoid cells and floating aggregates. The cell line has been eradicated from mycoplasma at ECACC.

應用

B lymphoma studies, cancer treatments

培養基

RPMI1640 + 2mM Glutamine + 15% Foetal Bovine Serum (FBS).

例行更新培養

Maintain cultures between 1-5 x 100,000 cells/ml;5% CO2; 37°C

其他說明

Additional freight & handling charges may be applicable for Asia-Pacific shipments. Please check with your local Customer Service representative for more information.

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门